152 related articles for article (PubMed ID: 30655567)
21. NHEJ-Mediated Repair of CRISPR-Cas9-Induced DNA Breaks Efficiently Corrects Mutations in HSPCs from Patients with Fanconi Anemia.
Román-Rodríguez FJ; Ugalde L; Álvarez L; Díez B; Ramírez MJ; Risueño C; Cortón M; Bogliolo M; Bernal S; March F; Ayuso C; Hanenberg H; Sevilla J; Rodríguez-Perales S; Torres-Ruiz R; Surrallés J; Bueren JA; Río P
Cell Stem Cell; 2019 Nov; 25(5):607-621.e7. PubMed ID: 31543367
[TBL] [Abstract][Full Text] [Related]
22. Proximal binding of dCas9 at a DNA double strand break stimulates homology-directed repair as a local inhibitor of classical non-homologous end joining.
Feng YL; Liu SC; Chen RD; Sun XN; Xiao JJ; Xiang JF; Xie AY
Nucleic Acids Res; 2023 Apr; 51(6):2740-2758. PubMed ID: 36864759
[TBL] [Abstract][Full Text] [Related]
23. Increasing CRISPR/Cas9-mediated homology-directed DNA repair by histone deacetylase inhibitors.
Li G; Zhang X; Wang H; Liu D; Li Z; Wu Z; Yang H
Int J Biochem Cell Biol; 2020 Aug; 125():105790. PubMed ID: 32534122
[TBL] [Abstract][Full Text] [Related]
24. Integration of xeno-free single-cell cloning in CRISPR-mediated DNA editing of human iPSCs improves homogeneity and methodological efficiency of cellular disease modeling.
Namipashaki A; Pugsley K; Liu X; Abrehart K; Lim SM; Sun G; Herold MJ; Polo JM; Bellgrove MA; Hawi Z
Stem Cell Reports; 2023 Dec; 18(12):2515-2527. PubMed ID: 37977144
[TBL] [Abstract][Full Text] [Related]
25. Harnessing accurate non-homologous end joining for efficient precise deletion in CRISPR/Cas9-mediated genome editing.
Guo T; Feng YL; Xiao JJ; Liu Q; Sun XN; Xiang JF; Kong N; Liu SC; Chen GQ; Wang Y; Dong MM; Cai Z; Lin H; Cai XJ; Xie AY
Genome Biol; 2018 Oct; 19(1):170. PubMed ID: 30340517
[TBL] [Abstract][Full Text] [Related]
26. CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites.
Jayavaradhan R; Pillis DM; Goodman M; Zhang F; Zhang Y; Andreassen PR; Malik P
Nat Commun; 2019 Jun; 10(1):2866. PubMed ID: 31253785
[TBL] [Abstract][Full Text] [Related]
27. Generation of genetically modified rat models via the CRISPR/Cas9 technology.
Liu MZ; Wang LR; Li YM; Ma XY; Han HH; Li DL
Yi Chuan; 2023 Jan; 45(1):78-87. PubMed ID: 36927640
[TBL] [Abstract][Full Text] [Related]
28. Transcription-coupled donor DNA expression increases homologous recombination for efficient genome editing.
Gao K; Zhang X; Zhang Z; Wu X; Guo Y; Fu P; Sun A; Peng J; Zheng J; Yu P; Wang T; Ye Q; Jiang J; Wang H; Lin CP; Gao G
Nucleic Acids Res; 2022 Oct; 50(19):e109. PubMed ID: 35929067
[TBL] [Abstract][Full Text] [Related]
29. Fast and Efficient Generation of Isogenic Induced Pluripotent Stem Cell Lines Using Adenine Base Editing.
Nami F; Ramezankhani R; Vandenabeele M; Vervliet T; Vogels K; Urano F; Verfaillie C
CRISPR J; 2021 Aug; 4(4):502-518. PubMed ID: 34406036
[TBL] [Abstract][Full Text] [Related]
30. Using CRISPR-Cas9 to Generate Gene-Corrected Autologous iPSCs for the Treatment of Inherited Retinal Degeneration.
Burnight ER; Gupta M; Wiley LA; Anfinson KR; Tran A; Triboulet R; Hoffmann JM; Klaahsen DL; Andorf JL; Jiao C; Sohn EH; Adur MK; Ross JW; Mullins RF; Daley GQ; Schlaeger TM; Stone EM; Tucker BA
Mol Ther; 2017 Sep; 25(9):1999-2013. PubMed ID: 28619647
[TBL] [Abstract][Full Text] [Related]
31. Combi-CRISPR: combination of NHEJ and HDR provides efficient and precise plasmid-based knock-ins in mice and rats.
Yoshimi K; Oka Y; Miyasaka Y; Kotani Y; Yasumura M; Uno Y; Hattori K; Tanigawa A; Sato M; Oya M; Nakamura K; Matsushita N; Kobayashi K; Mashimo T
Hum Genet; 2021 Feb; 140(2):277-287. PubMed ID: 32617796
[TBL] [Abstract][Full Text] [Related]
32. Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies.
Wang G; Yang L; Grishin D; Rios X; Ye LY; Hu Y; Li K; Zhang D; Church GM; Pu WT
Nat Protoc; 2017 Jan; 12(1):88-103. PubMed ID: 27929521
[TBL] [Abstract][Full Text] [Related]
33. Efficient Gene Editing of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.
Yumlu S; Bashir S; Stumm J; Kühn R
Methods Mol Biol; 2019; 1961():137-151. PubMed ID: 30912045
[TBL] [Abstract][Full Text] [Related]
34. CRISPR-Cas9-Based Genome Editing of Human Induced Pluripotent Stem Cells.
Giacalone JC; Sharma TP; Burnight ER; Fingert JF; Mullins RF; Stone EM; Tucker BA
Curr Protoc Stem Cell Biol; 2018 Feb; 44():5B.7.1-5B.7.22. PubMed ID: 29512106
[TBL] [Abstract][Full Text] [Related]
35. A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease.
Cai L; Bai H; Mahairaki V; Gao Y; He C; Wen Y; Jin YC; Wang Y; Pan RL; Qasba A; Ye Z; Cheng L
Stem Cells Transl Med; 2018 Jan; 7(1):87-97. PubMed ID: 29164808
[TBL] [Abstract][Full Text] [Related]
36. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
[TBL] [Abstract][Full Text] [Related]
37. A novel Cas9 fusion protein promotes targeted genome editing with reduced mutational burden in primary human cells.
Carusillo A; Haider S; Schäfer R; Rhiel M; Türk D; Chmielewski KO; Klermund J; Mosti L; Andrieux G; Schäfer R; Cornu TI; Cathomen T; Mussolino C
Nucleic Acids Res; 2023 May; 51(9):4660-4673. PubMed ID: 37070192
[TBL] [Abstract][Full Text] [Related]
38. P.F508del editing in cells from cystic fibrosis patients.
Smirnikhina SA; Kondrateva EV; Adilgereeva EP; Anuchina AA; Zaynitdinova MI; Slesarenko YS; Ershova AS; Ustinov KD; Yasinovsky MI; Amelina EL; Voronina ES; Yakushina VD; Tabakov VY; Lavrov AV
PLoS One; 2020; 15(11):e0242094. PubMed ID: 33175893
[TBL] [Abstract][Full Text] [Related]
39. Advance trends in targeting homology-directed repair for accurate gene editing: An inclusive review of small molecules and modified CRISPR-Cas9 systems.
Shams F; Bayat H; Mohammadian O; Mahboudi S; Vahidnezhad H; Soosanabadi M; Rahimpour A
Bioimpacts; 2022; 12(4):371-391. PubMed ID: 35975201
[No Abstract] [Full Text] [Related]
40. CRISPR/Cas9 Genome Editing of Human-Induced Pluripotent Stem Cells Followed by Granulocytic Differentiation.
Dannenmann B; Nasri M; Welte K; Skokowa J
Methods Mol Biol; 2020; 2115():471-483. PubMed ID: 32006418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
